VIDEO: Why plaque composition CT imaging may be the future of cardiology

AI-generated coronary tree from a patient's CT scan showing a color code of areas of interest for plaque burden from the Cleerly software shown at SCCT 2022.

AI-generated coronary tree from a patient's CT scan showing a color code of areas of interest for plaque burden from the Cleerly software shown at SCCT 2022.

Former European Society of Cardiology president Prof. Jeroen Bax explains the difficulty in quantifying these plaques manually and how artificial intelligence may change this to allow rapid, detailed quantitative analysis. 

Using a TAVR-like minimalist approach for valve-in-valve TMVR is safe and effective, Cleveland Clinic study confirms

Performing valve-in-valve transcatheter mitral valve replacement (ViV TMVR) with conscious sedation (CS) or monitored anesthesia care (MAC) instead of general anesthesia (GA) is safe and effective, according to new research published in JACC: Cardiovascular Interventions.

Image courtesy of Cleveland Clinic and JACC: Cardiovascular Interventions.

During valve-in-valve TMVR, patients are treated with conscious sedation or monitored anesthesia care instead of general anesthesia. This new analysis confirms that the change does not impact patient outcomes, but it was linked to a shorter length of stay.

Cardiac CT soft plaque assessment may offer paradigm shift for coronary disease screening

Left, coronary CT angiography of a vessel showing plaque heavy calcium burden. Right, image showing color code of various types of plaque morphology showing the complexity of these lesions. The right image was processed using the FDA cleared, AI-enabled plaque assessment from Elucid.

Elucid's AI analysis software in action. The left image shows coronary CT angiography of a vessel showing plaque heavy calcium burden. The right image, processed by Elucid's software, highlights the various types of plaque morphology of these lesions.

New artificial intelligence software that can evaluate coronary CT scans to automatically assess soft plaques were by far the biggest technology advance discussed at the Society of Cardiovascular Computed Tomography (SCCT) 2022 meeting. 

Subclinical leaflet thrombosis after TAVR: What we know, and still need to learn, about a challenging complication

Subclinical leaflet thrombosis after TAVR imaged by CT. The areas of clot attached to the valve leaflets appear dark. Image courtesy of Cahill et al. and JAMA Cardiology.

Subclinical leaflet thrombosis after TAVR imaged by CT. The areas of clot attached to the valve leaflets appear dark. Image courtesy of Cahill et al. and JAMA Cardiology.

Treating subclinical leaflet thrombosis after TAVR has been an ongoing challenge for structural heart clinicians, but recent research has gone a long way toward improving our understanding of this important topic. 

An immediate impact: Smartphone app boosts health of Black patients in just 10 weeks

LaPrincess Brewer, M.D., a Mayo Clinic preventive cardiologist and principal investigator of the study, explains a heart model.

LaPrincess Brewer, MD, a Mayo Clinic preventive cardiologist and principal investigator of the study, explains a heart model. Image is Courtesy of Mayo Clinic, and was taken prior to the COVID-19 pandemic.

Source

Image Courtesy of Mayo Clinic

A new trial for participants from 16 church groups in Minnesota showed that app users significantly improved their heart health scores after just 10 weeks.